Schaeffler plans to invest nearly 10 billion rupees in India in three years

According to the Economic Times of India, the Schaeffler Group recently stated that it will invest 150 million euros (about 10 billion rupees) to India to build a new expansion plant within three years.

Matthias Zink, head of Schaeffler's automotive business unit in Asia Pacific, said that Schaeffler will invest 150 million euros in the expansion of its three existing plants in India, and build a new plant in Savli, Gujarat, India. The new plant will be used to produce low friction balls. Bearings and so on.

Zink also stated that Schaeffler intends to recruit 1,200 new employees within three years, and that the number of employees in India will reach 3,500.

Schaeffler's major customers in India include Maruti Suzuki, Hyundai and Mahindra. Sales in the Indian market account for 5% of Schaeffler’s global sales.

Apalutamide API

Apalutamide is a small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity. Apalutamide binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes. This ultimately inhibits the expression of genes that regulate prostate cancer cell proliferation and may lead to an inhibition of cell growth in AR-expressing tumor cells.

Apalutamide Api,Apalutamide Api Project,Apalutamide Cas 956104-40-8,Apalutamice Inn Arn-509

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com